A multiomics study found that adolescent (but not adult) cannabinoid exposure in rats reprogrammed the prefrontal cortex response to cocaine, altering gene expression, histone acetylation, and protein phosphorylation.
Addiction neuroscientists, developmental researchers, and adolescent substance use prevention advocates.
Adolescent (not adult) cannabinoid exposure reprogrammed brain response to cocaine
What the researchers found
Adolescent rats pre-exposed to the synthetic cannabinoid WIN showed cross-sensitization to cocaine, correlating with histone hyperacetylation and decreased HDAC6 in the prefrontal cortex. WIN preexposure blunted the typical mRNA response to cocaine, instead producing alternative splicing and chromatin accessibility changes. Protein phosphorylation was enhanced (ERK/MAPK targets including gephyrin), and AMPAR/GluR synaptic composition was altered in both PFC and nucleus accumbens. These effects were specific to adolescent exposure.
Why it matters
This provides the first molecular and epigenetic evidence for how adolescent cannabis exposure could increase vulnerability to cocaine. The multiomics approach reveals that cannabinoids do not just change behavior; they fundamentally reprogram how the brain responds to a new drug.
The numbers in context
Adolescent (not adult) WIN exposure caused cross-sensitization to cocaine; histone hyperacetylation and decreased HDAC6 in PFC; blunted mRNA response; enhanced ERK/MAPK phosphorylation; altered AMPAR/GluR composition in PFC and NAcc.
How the study worked
Multiomics approach (epigenomics, transcriptomics, proteomics, phosphoproteomics) characterizing the rat brain response to first cocaine exposure, with or without adolescent preexposure to the synthetic cannabinoid WIN 55,212-2. Published in PNAS.
What this study cannot tell us
Synthetic cannabinoid (WIN) not identical to THC or cannabis; rat model; single cocaine exposure (does not model addiction); epigenetic changes may not persist long-term; cannot confirm same mechanisms in human adolescents; PNAS rigor but still preclinical.
How to read the evidence
Moderate: rigorous multiomics approach published in PNAS, but preclinical with synthetic cannabinoid.
When this study was published
Published 2020.
The bigger picture
The "gateway drug" hypothesis has been debated for decades. This study provides molecular-level evidence supporting a specific mechanism: adolescent cannabinoid exposure epigenetically reprograms the brain to respond differently to cocaine, but only during the developmental window of adolescence.
Questions still open
- Would THC produce the same molecular reprogramming as the synthetic cannabinoid used? Is there a human-relevant age window where cannabis exposure creates similar vulnerability?
Common questions
Does teenage cannabis use make cocaine more addictive?
Is this the "gateway drug" effect?
Read the original research
Cannabinoid exposure in rat adolescence reprograms the initial behavioral, molecular, and epigenetic response to cocaine.
Proceedings of the National Academy of Sciences of the United States of America, 117(18), 9991-10002
Citation
Scherma, Maria; Qvist, Johanna S; Asok, Arun; Huang, Shao-Shan C; Masia, Paolo; Deidda, Matteo; Wei, Ya B; Soni, Rajesh K; Fratta, Walter; Fadda, Paola; Kandel, Eric R; Kandel, Denise B; Melas, Philippe A. (2020). Cannabinoid exposure in rat adolescence reprograms the initial behavioral, molecular, and epigenetic response to cocaine.. Proceedings of the National Academy of Sciences of the United States of America, 117(18), 9991-10002. https://doi.org/10.1073/pnas.1920866117
Explore the wider topic
- How to Talk to Your Teenager About Weed (Without Losing Them)
- My Kid's Friends Smoke Weed: A Parent's Guide
- I Smoke Weed But Don't Want My Kids To: Navigating the Hypocrisy
- Quitting Weed as a Parent: Why It Is the Hardest and Most Important Quit
- Quitting Weed as a Teen or Young Adult
- My Kid Is Smoking Weed: A Parent's Guide